fda glp-1 compounding warning september 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads FDA Sends Warning Letters to
Description
The Physiology of Glucagon
Sci Transl Med 9(404):eaan0972 Mitchell JL et al (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
GLP-1 is a hormone that your body produces in response to food intake
As of January 2026, only 13 state Medicaid programs covered GLP-1s for obesity treatment
Consulting with a healthcare provider is essential to determine if Ozempic or Zepbound is right for your needs
The impulse economy is wobbling Food companies are already starting to see the commercial effects
